Search Results - "Kehl, Niklas"

Refine Results
  1. 1

    Cancer-type organic anion transporting polypeptide 1B3 (Ct-OATP1B3) is localized in lysosomes and mediates resistance against kinase inhibitors by Haberkorn, Bastian, Oswald, Stefan, Kehl, Niklas, Gessner, Arne, Taudte, R Verena, Dobert, Jan Philipp, Zunke, Friederike, Fromm, Martin F, König, Jörg

    Published in Molecular pharmacology (01-12-2022)
    “…Cancer-type organic anion transporting polypeptide 1B3 (Ct-OATP1B3), a splice variant of the hepatic uptake transporter OATP1B3 (liver-type; Lt-OATP1B3), is…”
    Get full text
    Journal Article
  2. 2

    Intrathecal activation of CD8+ memory T cells in IgG4‐related disease of the brain parenchyma by Friedrich, Mirco, Kehl, Niklas, Engelke, Niko, Kraus, Josephine, Lindner, Katharina, Münch, Philipp, Mildenberger, Iris, Groden, Christoph, Gass, Achim, Etminan, Nima, Fatar, Marc, von Deimling, Andreas, Reuss, David, Platten, Michael, Bunse, Lukas

    Published in EMBO molecular medicine (09-08-2021)
    “…IgG4‐related disease (IgG4‐RD) is a fibroinflammatory disorder signified by aberrant infiltration of IgG4‐restricted plasma cells into a variety of organs…”
    Get full text
    Journal Article
  3. 3
  4. 4

    857 Dose- and time-dependent immune cell dynamics in irradiated gliomas by Agardy, Dennis A, Michel, Julius, Boztepe, Berin, Hunger, Jessica, Kehl, Niklas, Kourtesakis, Alexandros, Geller, Julia, Chih, Yu-Chan, Jähne, Kristine, Sachs, Viktoria, Fischer, Manuel, Breckwoldt, Michael, Wick, Wolfgang, Bunse, Theresa, Bunse, Lukas, Platten, Michael

    Published in Journal for immunotherapy of cancer (01-11-2023)
    “…BackgroundResection followed by radio-chemotherapy remains the mainstay of standard-of-care for patients with malignant brain tumors. Immunotherapies such as…”
    Get full text
    Journal Article
  5. 5

    Rhodium‐Catalyzed Anti‐Markovnikov Transfer Hydroiodination of Terminal Alkynes by Boehm, Philip, Kehl, Niklas, Morandi, Bill

    Published in Angewandte Chemie International Edition (23-01-2023)
    “…A rhodium‐catalyzed anti‐Markovnikov hydroiodination of aromatic and aliphatic terminal alkynes is reported. Depending on the choice of ligand and substrate,…”
    Get full text
    Journal Article
  6. 6

    Dysfunctional dendritic cells limit antigen-specific T cell response in glioma by Friedrich, Mirco, Hahn, Markus, Michel, Julius, Sankowski, Roman, Kilian, Michael, Kehl, Niklas, Günter, Manina, Bunse, Theresa, Pusch, Stefan, von Deimling, Andreas, Wick, Wolfgang, Autenrieth, Stella E, Prinz, Marco, Platten, Michael, Bunse, Lukas

    Published in Neuro-oncology (Charlottesville, Va.) (14-02-2023)
    “…Dendritic cells (DC), the most potent professional antigen presenting cells capable of effective cross-presentation, have been demonstrated to license T helper…”
    Get full text
    Journal Article
  7. 7

    Rhodium‐katalysierte Anti‐Markovnikov Hydroiodierung von Terminalen Alkinen by Boehm, Philip, Kehl, Niklas, Morandi, Bill

    Published in Angewandte Chemie (23-01-2023)
    “…Wir beschreiben eine Rhodium‐katalysierte anti‐Markovnikov Hydroiodierung von terminalen aromatischen und aliphatischen Alkinen. Je nach Wahl des Liganden und…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    A supervised machine-learning approach for the efficient development of a multi method (LC-MS) for a large number of drugs and subsets thereof: focus on oral antitumor agents by Kehl, Niklas, Gessner, Arne, Maas, Renke, Fromm, Martin F, Taudte, R Verena

    Published in Clinical chemistry and laboratory medicine (26-01-2024)
    “…Accumulating evidence argues for a more widespread use of therapeutic drug monitoring (TDM) to support individualized medicine, especially for therapies where…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13

    Entwicklung, Optimierung, Validierung und Anwendung Einer LC-MS Methode für die Simultane Quantifizierung Einer Vielzahl von Oralen Antitumortherapeutika In Humanplasma als Basis für Eine Zukünftige, Routinemäßige Expositionsabschätzung von Tumorpatienten by Kehl, Niklas

    Published 01-01-2024
    “…Tumorerkrankungen sind für etwa 25 % aller Todesfälle in Deutschland verantwortlich und nach Herz-Kreislauf-Erkrankungen die zweithäufigste Todesursache. Die…”
    Get full text
    Dissertation
  14. 14
  15. 15
  16. 16

    An Easily Expandable Multi-Drug LC-MS Assay for the Simultaneous Quantification of 57 Oral Antitumor Drugs in Human Plasma by Kehl, Niklas, Schlichtig, Katja, Dürr, Pauline, Bellut, Laura, Dörje, Frank, Fietkau, Rainer, Pavel, Marianne, Mackensen, Andreas, Wullich, Bernd, Maas, Renke, Fromm, Martin F, Gessner, Arne, Taudte, R Verena

    Published in Cancers (16-12-2021)
    “…Oral anticancer drugs have led to significant improvements in the treatment of multiple tumor entities. However, in patients undergoing oral antitumor therapy,…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20